Pneumonia News and Research

Latest Pneumonia News and Research

Cempra reports net loss of $10.3 million in first quarter 2013

Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the first quarter ended March 31, 2013.

26 Apr 2013

Study: Regional anesthesia associated with with fewer postoperative complications in orthopedic surgery patients

A study published in the May issue of Anesthesiology discovered that spinal or epidural anesthesia, types of regional anesthesia that numb patients from the abdomen to the toes, were associated with fewer postoperative complications and death than general anesthesia in patients undergoing primary hip or knee replacement.

25 Apr 2013

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

24 Apr 2013

Research roundup: Community benefits and hospitals' tax-exempt status; Medicaid expansion could benefit people of color; Looking at changes for Medicare

The federal health law requires tax-exempt hospitals to assess and address the needs of the community in which they serve by the end of 2013.

20 Apr 2013

Research shows respiratory syncytial virus can be transferred during pregnancy to unborn baby

The most common cause of lower respiratory tract infections in infants and young children, respiratory syncytial virus (RSV), can be transferred during pregnancy to an unborn baby, according to Cleveland Clinic Children's Hospital research published online this week in the journal PLOS ONE.

19 Apr 2013

Global experts highlight strategies to immunize more children

In advance of World Immunization Week, global experts are highlighting strategies to further advance progress on the Global Vaccine Action Plan that was endorsed by the World Health Assembly, 2012.

19 Apr 2013

AACN Practice Alert outlines evidence-based protocols related to bathing adult patients

The long-held tradition of using a basin, soap and water to bathe bed-bound hospitalized patients is no longer the recommended standard of practice, according to the American Association of Critical-Care Nurses.

19 Apr 2013

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

19 Apr 2013

Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution

Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.

19 Apr 2013

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

18 Apr 2013

Reducing preventable hospital readmissions may take longer, say researchers

Achieving widespread reductions in preventable hospital readmissions among Medicare beneficiaries may take longer than many health care professionals originally anticipated, according to researchers at Penn State, the Weill Cornell Medical College and the University of Pennsylvania.

18 Apr 2013

Health officials have reason to 'remain hypervigilant' over H7N9

"Just as the world was breathing easier about a deadly bird flu virus that killed 371 people over the past decade before dropping out of sight, a different form of bird flu has emerged in China that is causing concern among health experts," a New York Times editorial writes.

18 Apr 2013

GAPPD presents opportunity to meld global, local agendas

"Beyond integration across the two diseases, the [Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD) released by the WHO and UNICEF last week] is an opportunity to meld global and local agendas, giving national governments a comprehensive tool to determine the specific plans, investments, and partners needed to address the unique needs of their countries and achieve the greatest health impact for their citizens," PATH CEO Steve Davis writes in the Huffington Post's "Global Motherhood" blog.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

A study published today in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation, the opposite of results just published by another group in the same journal analyzing the same data.

17 Apr 2013

Large numbers of ER visits go unreported in calculating hospital readmission rates

A study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Boston University School of Medicine has found that nearly one quarter of patients may return to the emergency department within 30 days of being discharged from a hospitalization.

17 Apr 2013

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

Gates Foundation's programs complement new global plan to prevent 2M child deaths

John Grove, a senior program officer at the Bill & Melinda Gates Foundation, and Gretchen Meller, a program officer at the foundation, write in the group's "Impatient Optimists" blog, "By addressing [pneumonia and diarrhea] together, the [Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea] goes to the heart of the matter: both diseases are caused by a range of pathogens, and no single intervention alone will eliminate either disease.

15 Apr 2013

WHO, UNICEF launch new Global Action Plan to save children from pneumonia and diarrhoea

A new Global Action Plan launched today by the WHO and UNICEF has the potential to save up to 2 million children every year from deaths caused by pneumonia and diarrhoea, some of the leading killers of children under five globally.

15 Apr 2013

China reports additional deaths from H7N9; Scientists work to uncover source

"China reported two more fatalities from a new strain of avian flu [H7N9] on Tuesday, bringing the death toll to nine, and raised the total number of infections by four to 28 as the government renewed efforts to combat the spread of the disease," the Wall Street Journal reports (Tejada/Burkitt, 4/9).

11 Apr 2013

Pneumonia News and Research

Latest Pneumonia News and Research

Cempra reports net loss of $10.3 million in first quarter 2013

Study: Regional anesthesia associated with with fewer postoperative complications in orthopedic surgery patients

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Research roundup: Community benefits and hospitals' tax-exempt status; Medicaid expansion could benefit people of color; Looking at changes for Medicare

Research shows respiratory syncytial virus can be transferred during pregnancy to unborn baby

Global experts highlight strategies to immunize more children

AACN Practice Alert outlines evidence-based protocols related to bathing adult patients

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Reducing preventable hospital readmissions may take longer, say researchers

Health officials have reason to 'remain hypervigilant' over H7N9

GAPPD presents opportunity to meld global, local agendas

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Large numbers of ER visits go unreported in calculating hospital readmission rates

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Gates Foundation's programs complement new global plan to prevent 2M child deaths

WHO, UNICEF launch new Global Action Plan to save children from pneumonia and diarrhoea

China reports additional deaths from H7N9; Scientists work to uncover source

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Pneumonia News and Research

Latest Pneumonia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in